Micropharm Limited in Newcastle Emlyn, SA38 9BY

Description

Data updated on: 01-11-2023

The Micropharm Limited firm has been on the market for at least 26 years, as it's been founded in 1998. Registered with number 03617656, Micropharm was set up as a Private Limited Company located in Units F & G Station Road Industrial Estate, Newcastle Emlyn SA38 9BY. This enterprise's SIC code is 21100: Manufacture of basic pharmaceutical products. Thursday 31st March 2022 is the last time when the company accounts were filed.

The trademark of Micropharm is "EBOTAb". It was applied for in November, 2015 and its registration process was finalised by IPO in January, 2016. The firm will use their trademark untill November, 2025.

In order to meet the requirements of their clientele, the following company is being guided by a group of four directors who are, to enumerate a few, David F., David W. and Ian C.. Their support has been of crucial importance to this specific company for ten years.

Trade marks

Trademark UK00003134480

Trademark UK00003134480

Trademark image:	-
Trademark name:	EBOTAb
Status:	Registered
Filing date:	2015-11-03
Date of entry in register:	2016-01-22
Renewal date:	2025-11-03
Owner name:	Micropharm Limited
Owner address:	Micropharm Ltd, Unit F-G, Station Road, NEWCASTLE EMLYN, United Kingdom, SA38 9BY

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-09-30	2013-09-30	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	1 123 370	850 575	1 885 206

Balance Sheet
Cash Bank In Hand	338 582	152 644	920 686
Cash Bank On Hand				2 117 424	951 863	752 006	456 500
Current Assets	1 072 296	806 694	1 953 960	3 462 079	2 270 938	3 943 010	4 671 983
Debtors	263 479	362 410	451 506	410 393	518 950	1 399 186	1 080 810
Net Assets Liabilities				4 081 185	3 167 218	2 677 483	2 404 261
Net Assets Liabilities Including Pension Asset Liability	1 123 370	850 575	1 885 206
Other Debtors				359 819	498 605	173 539	16 151
Property Plant Equipment				1 030 542	1 375 891	1 668 558	3 459 587
Stocks Inventory	470 235	291 640	581 768
Tangible Fixed Assets	180 434	163 917	281 733
Total Inventories				934 262	800 125	1 791 818	3 134 673

Capital & Reserves
Called Up Share Capital	756 000	776 000	1 023 500
Profit Loss Account Reserve	346 370	43 575	127 206
Shareholder Funds	1 123 370	850 575	1 885 206

Other Financial Data
Accruals Deferred Income	14 820	12 444	21 484
Accrued Liabilities					145 742	150 111	359 162
Accrued Liabilities Not Expressed Within Creditors Subtotal				52 328	44 181	137 084	117 577
Accumulated Amortisation Impairment Intangible Assets						37 876	220 820
Accumulated Depreciation Impairment Property Plant Equipment				774 898	851 818	961 704	1 148 450
Amounts Owed To Group Undertakings							640 365
Average Number Employees During Period					39	45	52
Capital Redemption Reserve	21 000	31 000	31 000
Corporation Tax Recoverable					190 591	148 340	105 359
Creditors				2 634	1 772	41 729	29 203
Creditors Due After One Year			3 497
Creditors Due Within One Year	114 540	107 592	325 506
Disposals Decrease In Depreciation Impairment Property Plant Equipment					11 783	33 397
Disposals Property Plant Equipment					12 000	121 537
Finance Lease Liabilities Present Value Total				2 634	1 772	41 729	29 203
Fixed Assets					1 375 891	2 727 752	5 214 686
Government Grants Payable					8 147	25 269	18 561
Increase Decrease In Property Plant Equipment						58 896
Increase From Amortisation Charge For Year Intangible Assets						37 876	182 944
Increase From Depreciation Charge For Year Property Plant Equipment					88 703	143 283	186 747
Intangible Assets						1 059 194	1 755 099
Intangible Assets Gross Cost						1 097 070	1 975 919
Merchandise					765 125	1 756 853	2 573 309
Net Current Assets Liabilities	957 756	699 102	1 628 454	3 105 605	1 837 280	128 542	-2 663 645
Number Shares Allotted	7 560 002	7 760 002	10 235 002
Other Creditors				160 427	155 309	2 155	6 237
Other Remaining Borrowings						3 179 615	5 185 140
Other Taxation Social Security Payable				7 810	36 842	41 383	47 848
Par Value Share		0	0
Prepayments					51 191	25 276	53 686
Property Plant Equipment Gross Cost				1 805 440	2 227 709	2 630 263	4 608 037
Recoverable Value-added Tax							164 402
Share Capital Allotted Called Up Paid		776 000	1 023 500
Share Premium Account			703 500
Tangible Fixed Assets Additions		16 332	161 238
Tangible Fixed Assets Cost Or Valuation	881 366	897 698	1 009 999
Tangible Fixed Assets Depreciation	700 932	733 781	728 266
Tangible Fixed Assets Depreciation Charged In Period		32 849	43 422
Tangible Fixed Assets Depreciation Decrease Increase On Disposals			48 937
Tangible Fixed Assets Disposals			48 937
Total Additions Including From Business Combinations Intangible Assets						1 097 070	878 849
Total Additions Including From Business Combinations Property Plant Equipment					434 269	524 090	1 977 774
Total Assets Less Current Liabilities	1 138 190	863 019	1 910 187	4 136 147	3 213 171	2 856 294	2 551 041
Trade Creditors Trade Payables				187 374	240 548	285 086	1 065 789
Trade Debtors Trade Receivables				50 574	20 345	825 970	627 716
Value Shares Allotted	756 000	776 000
Work In Progress					35 000	34 965	561 364
Advances Credits Directors	25 000	255 000
Advances Credits Made In Period Directors	25 000	200 000
Advances Credits Repaid In Period Directors		25 000

Company staff

David F.

Role: Director

Appointed: 29 September 2014

Latest update: 2 April 2024

David W.

Role: Director

Appointed: 29 September 2014

Latest update: 2 April 2024

Ian C.

Role: Director

Appointed: 12 April 2010

Latest update: 2 April 2024

John L.

Role: Director

Appointed: 18 August 1998

Latest update: 2 April 2024

Geoffrey S.

Role: Director

Appointed: 12 April 2010

Resigned: 29 July 2014

Latest update: 2 April 2024

Aboulsalami N.

Role: Director

Appointed: 23 May 2001

Resigned: 12 April 2010

Latest update: 2 April 2024

Ian C.

Role: Director

Appointed: 03 April 2001

Resigned: 20 February 2008

Latest update: 2 April 2024

Gerrit M.

Role: Director

Appointed: 05 December 2000

Resigned: 12 September 2006

Latest update: 2 April 2024

Ruth C.

Role: Director

Appointed: 18 August 1998

Resigned: 31 August 2023

Latest update: 2 April 2024

Ruth C.

Role: Secretary

Appointed: 18 August 1998

Resigned: 29 September 2014

Latest update: 2 April 2024

David R.

Role: Director

Appointed: 18 August 1998

Resigned: 01 October 2001

Latest update: 2 April 2024

People with significant control

The companies with significant control over this firm are as follows: Flynn Pharma (Holdings) Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Stevenage at Primett Road, SG1 3EE, Hertfordshire and was registered as a PSC under the reg no 05875486.

Flynn Pharma (Holdings) Limited

Address: Second Floor, Hertlands House Primett Road, Stevenage, Hertfordshire, SG1 3EE, United Kingdom

Legal authority Companies Act 2013

Legal form Limited Company

Country registered England And Wales

Place registered England & Wales

Registration number 05875486

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	01 September 2024
Confirmation statement last made up date	18 August 2023

Annual Accounts
Start Date For Period Covered By Report	01 October 2012
End Date For Period Covered By Report	30 September 2013
Annual Accounts 4 June 2015
Start Date For Period Covered By Report	01 October 2013
End Date For Period Covered By Report	31 March 2015
Date Approval Accounts	4 June 2015
Annual Accounts
Start Date For Period Covered By Report	01 April 2016
End Date For Period Covered By Report	31 March 2017
Annual Accounts
Start Date For Period Covered By Report	01 April 2017
End Date For Period Covered By Report	31 March 2018
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts 21 February 2014
Date Approval Accounts	21 February 2014

Micropharm Limited

General information

Name:

Office Address:

Description

Trade marks

Trademark UK00003134480

Financial data based on annual reports

Company staff

David F.

David W.

Ian C.

John L.

Geoffrey S.

Aboulsalami N.

Ian C.

Gerrit M.

Ruth C.

Ruth C.

David R.

People with significant control

Flynn Pharma (Holdings) Limited

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode